JP2012031131A - ロキソプロフェン含有医薬組成物 - Google Patents

ロキソプロフェン含有医薬組成物 Download PDF

Info

Publication number
JP2012031131A
JP2012031131A JP2011017776A JP2011017776A JP2012031131A JP 2012031131 A JP2012031131 A JP 2012031131A JP 2011017776 A JP2011017776 A JP 2011017776A JP 2011017776 A JP2011017776 A JP 2011017776A JP 2012031131 A JP2012031131 A JP 2012031131A
Authority
JP
Japan
Prior art keywords
salt
loxoprofen
loxoprofen sodium
hydrochloride
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011017776A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012031131A5 (zh
Inventor
Toshiki Usui
俊樹 薄井
Masaaki Haruhara
政明 春原
Masaya Takamiya
雅哉 高宮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Priority to JP2011017776A priority Critical patent/JP2012031131A/ja
Publication of JP2012031131A publication Critical patent/JP2012031131A/ja
Publication of JP2012031131A5 publication Critical patent/JP2012031131A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2011017776A 2010-01-29 2011-01-31 ロキソプロフェン含有医薬組成物 Pending JP2012031131A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011017776A JP2012031131A (ja) 2010-01-29 2011-01-31 ロキソプロフェン含有医薬組成物

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP2010018015 2010-01-29
JP2010018015 2010-01-29
JP2010149115 2010-06-30
JP2010149061 2010-06-30
JP2010149061 2010-06-30
JP2010149089 2010-06-30
JP2010149115 2010-06-30
JP2010149089 2010-06-30
JP2011017776A JP2012031131A (ja) 2010-01-29 2011-01-31 ロキソプロフェン含有医薬組成物

Publications (2)

Publication Number Publication Date
JP2012031131A true JP2012031131A (ja) 2012-02-16
JP2012031131A5 JP2012031131A5 (zh) 2013-03-14

Family

ID=44319475

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011017776A Pending JP2012031131A (ja) 2010-01-29 2011-01-31 ロキソプロフェン含有医薬組成物
JP2011512760A Active JP4787912B2 (ja) 2010-01-29 2011-01-31 ロキソプロフェン含有医薬組成物
JP2011136591A Pending JP2012031147A (ja) 2010-01-29 2011-06-20 ロキソプロフェン含有医薬組成物
JP2013182739A Active JP5575961B2 (ja) 2010-01-29 2013-09-04 ロキソプロフェン含有医薬組成物
JP2014130149A Active JP5809736B2 (ja) 2010-01-29 2014-06-25 ロキソプロフェン含有新医薬組成物

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2011512760A Active JP4787912B2 (ja) 2010-01-29 2011-01-31 ロキソプロフェン含有医薬組成物
JP2011136591A Pending JP2012031147A (ja) 2010-01-29 2011-06-20 ロキソプロフェン含有医薬組成物
JP2013182739A Active JP5575961B2 (ja) 2010-01-29 2013-09-04 ロキソプロフェン含有医薬組成物
JP2014130149A Active JP5809736B2 (ja) 2010-01-29 2014-06-25 ロキソプロフェン含有新医薬組成物

Country Status (4)

Country Link
JP (5) JP2012031131A (zh)
KR (1) KR20120112644A (zh)
CN (1) CN102740854A (zh)
WO (1) WO2011093498A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013018765A1 (ja) * 2011-07-29 2013-02-07 興和株式会社 ロキソプロフェンを含有する医薬組成物
JP2014159406A (ja) * 2013-01-28 2014-09-04 Taisho Pharmaceutical Co Ltd 固形製剤

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5525324B2 (ja) * 2009-04-28 2014-06-18 興和株式会社 ロキソプロフェン含有医薬製剤
JP5525323B2 (ja) * 2009-04-28 2014-06-18 興和株式会社 ロキソプロフェン含有医薬製剤
JP5624367B2 (ja) * 2009-05-28 2014-11-12 興和株式会社 ロキソプロフェン含有医薬製剤
TWI680757B (zh) * 2010-12-28 2020-01-01 日商興和股份有限公司 解熱鎮痛組成物
WO2013018766A1 (ja) * 2011-07-29 2013-02-07 興和株式会社 安定な医薬組成物
WO2013047869A1 (ja) * 2011-09-29 2013-04-04 興和株式会社 ロキソプロフェン又はその塩を含有する医薬組成物
JP6114573B2 (ja) * 2012-02-29 2017-04-12 第一三共ヘルスケア株式会社 ロキソプロフェンナトリウムと制酸剤を含有する固形製剤
WO2014002599A1 (ja) * 2012-06-25 2014-01-03 興和株式会社 生薬等含有医薬組成物
JP6197513B2 (ja) * 2012-11-09 2017-09-20 大正製薬株式会社 医薬組成物
JP6149625B2 (ja) * 2012-11-09 2017-06-21 大正製薬株式会社 医薬組成物
CN103333064B (zh) * 2013-07-17 2014-04-23 珠海金鸿药业股份有限公司 洛索洛芬钠化合物及其药物组合物
CN104225160A (zh) * 2014-09-28 2014-12-24 白杨 一种包衣处理的七味都气丸的制备方法
CN104225187A (zh) * 2014-09-28 2014-12-24 白杨 一种包衣处理的知柏地黄丸的制备方法
CN104288433A (zh) * 2014-09-28 2015-01-21 白杨 一种包衣处理的枸菊地黄丸的制备方法
CN104225162A (zh) * 2014-09-28 2014-12-24 白杨 一种包衣处理的桂附地黄丸的制备方法
CN104257984A (zh) * 2014-09-28 2015-01-07 白杨 一种包衣处理的六味地黄丸的制备方法
CN104225161A (zh) * 2014-09-28 2014-12-24 白杨 一种包衣处理的归芍地黄丸的制备方法
CN104224740A (zh) * 2014-09-28 2014-12-24 白杨 一种包衣处理的百合固金丸的制备方法
CN106580968A (zh) * 2016-11-22 2017-04-26 郑州仁宏医药科技有限公司 一种治疗牙齿肿痛的西药散剂及其制备方法
EP3415143A1 (en) * 2017-06-16 2018-12-19 Kai-Uwe Kern Bromhexine for the treatment of pain
CN113332252A (zh) * 2021-06-07 2021-09-03 大桐制药（中国）有限责任公司 一种洛索洛芬钠片的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000143505A (ja) * 1998-11-06 2000-05-23 Sankyo Co Ltd ロキソプロフェンを含有する医薬組成物
JP2008285475A (ja) * 2007-04-17 2008-11-27 Daiichi Sankyo Healthcare Co Ltd ロキソプロフェンを含有する抗アデノウイルス剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033704A1 (fr) * 1995-04-26 1996-10-31 Taisho Pharmaceutical Co., Ltd. Preparation pour administration orale
JP4828707B2 (ja) * 2000-02-28 2011-11-30 武田薬品工業株式会社 固形圧縮製剤
JPWO2004017954A1 (ja) * 2002-08-22 2005-12-08 小野薬品工業株式会社 ジクロフェナクの副作用軽減剤
EP1815852B1 (en) * 2004-11-05 2017-01-25 Lead Chemical Co. Ltd. Nonaqueous preparation for percutaneous absorption containing nonsteroidal antiflammatory analgesic
JP4853818B2 (ja) * 2005-08-24 2012-01-11 大正製薬株式会社 イブプロフェン及び塩酸アンブロキソール含有固形製剤
JP5465824B2 (ja) * 2006-03-24 2014-04-09 第一三共ヘルスケア株式会社 医薬用製剤およびその製造方法
WO2008069283A1 (ja) * 2006-12-06 2008-06-12 Nipro Patch Co., Ltd. 外用医薬組成物及び貼付剤
JP2010215611A (ja) * 2009-01-28 2010-09-30 Kowa Co ロキソプロフェン含有医薬製剤
JP2010235599A (ja) * 2009-03-11 2010-10-21 Kowa Co ロキソプロフェン含有医薬製剤
JP2011006407A (ja) * 2009-05-28 2011-01-13 Kowa Co ロキソプロフェン含有医薬製剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000143505A (ja) * 1998-11-06 2000-05-23 Sankyo Co Ltd ロキソプロフェンを含有する医薬組成物
JP2008285475A (ja) * 2007-04-17 2008-11-27 Daiichi Sankyo Healthcare Co Ltd ロキソプロフェンを含有する抗アデノウイルス剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6013011000; 牧亨: '一般薬の製剤設計方略' 医薬品製剤化方略と新技術 , 2007, ｐ．２５-２９ *
JPN7013000887; 第一三共株式会社: 医薬品インタビューフォーム「ロキソニン錠、ロキソニン細粒」 第３版, 2007, ｐ．１０-１１ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013018765A1 (ja) * 2011-07-29 2013-02-07 興和株式会社 ロキソプロフェンを含有する医薬組成物
JP2014159406A (ja) * 2013-01-28 2014-09-04 Taisho Pharmaceutical Co Ltd 固形製剤

Also Published As

Publication number Publication date
JP5575961B2 (ja) 2014-08-20
JP5809736B2 (ja) 2015-11-11
JPWO2011093498A1 (ja) 2013-06-06
JP2013237710A (ja) 2013-11-28
JP2014169345A (ja) 2014-09-18
KR20120112644A (ko) 2012-10-11
JP4787912B2 (ja) 2011-10-05
CN102740854A (zh) 2012-10-17
WO2011093498A1 (ja) 2011-08-04
JP2012031147A (ja) 2012-02-16

Similar Documents

Publication Publication Date Title
JP5809736B2 (ja) ロキソプロフェン含有新医薬組成物
JP6345318B2 (ja) ロキソプロフェン含有医薬製剤
JP2016155860A (ja) ロキソプロフェン含有医薬製剤
JP2012097002A (ja) ロキソプロフェン含有医薬製剤
JP5571237B2 (ja) ロキソプロフェン含有医薬組成物
JP5525324B2 (ja) ロキソプロフェン含有医薬製剤
JP2011046692A (ja) 医薬製剤
JP5624367B2 (ja) ロキソプロフェン含有医薬製剤
JP5798800B2 (ja) ロキソプロフェン含有医薬製剤
JP5525323B2 (ja) ロキソプロフェン含有医薬製剤
JP5611651B2 (ja) ロキソプロフェン含有医薬製剤
JP5796942B2 (ja) ロキソプロフェン含有の医薬組成物
JP2011116750A (ja) ロキソプロフェン含有医薬組成物
JP5681430B2 (ja) ロキソプロフェン含有医薬組成物
JP5433053B2 (ja) ロキソプロフェン含有医薬組成物
WO2012157752A1 (ja) ロキソプロフェン含有の医薬組成物
JP2011132226A (ja) ロキソプロフェン含有医薬組成物及び該組成物を含む医薬製剤
JP5798734B2 (ja) ロキソプロフェン含有医薬の組成物
JP6145143B2 (ja) シクロアルカン誘導体又はその塩の含有医薬製剤
JP5758100B2 (ja) ロキソプロフェン含有医薬組成物
JP2016014063A (ja) ロキソプロフェン含有医薬組成物

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130129

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130129

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20130129

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20130220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130312

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130513

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130604